USP8 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.02099464835715E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.84320000001992E-06 |
Normal-vs-Stage2 |
3.263900E-03 |
Normal-vs-Stage3 |
1.0547118733939E-14 |
Normal-vs-Stage4 |
1.68953739887456E-12 |
Stage1-vs-Stage2 |
9.432000E-01 |
Stage1-vs-Stage3 |
1.62564999999226E-05 |
Stage1-vs-Stage4 |
1.8163199999921E-05 |
Stage2-vs-Stage3 |
1.993650E-02 |
Stage2-vs-Stage4 |
1.007610E-02 |
Stage3-vs-Stage4 |
5.778000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.55769866292144E-11 |
Normal-vs-AfricanAmerican |
5.63169999967528E-07 |
Normal-vs-Asian |
1.032420E-01 |
Caucasian-vs-AfricanAmerican |
7.203200E-01 |
Caucasian-vs-Asian |
4.443200E-01 |
AfricanAmerican-vs-Asian |
3.867400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
8.02170552205439E-11 |
Normal-vs-Female |
5.43760000359939E-08 |
Male-vs-Female |
1.219440E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.8864799999907E-05 |
Normal-vs-Age(41-60Yrs) |
4.41320000543755E-08 |
Normal-vs-Age(61-80Yrs) |
6.56208420934945E-12 |
Normal-vs-Age(81-100Yrs) |
2.38630000004569E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.428400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.192000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.957400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.018400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.332200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.811400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
9.148000E-01 |
Normal-vs-Grade 2 |
1.62241999999146E-05 |
Normal-vs-Grade 3 |
1.69397829097306E-12 |
Normal-vs-Grade 4 |
1.62436730732907E-12 |
Grade 1-vs-Grade 2 |
8.305600E-02 |
Grade 1-vs-Grade 3 |
2.845100E-04 |
Grade 1-vs-Grade 4 |
8.4027000002429E-07 |
Grade 2-vs-Grade 3 |
9.85270000000149E-05 |
Grade 2-vs-Grade 4 |
3.36609995432724E-09 |
Grade 3-vs-Grade 4 |
3.518500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.764700E-04 |
Normal-vs-ccB subtype |
3.48021611529248E-12 |
ccA subtype-vs-ccB subtype |
1.18979999996771E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
7.97620003378796E-09 |
Normal-vs-N1 |
3.94380000000583E-05 |
N0-vs-N1 |
2.713200E-01 |
|
|